However , the presently observed trend towards CpG -specific MAO-A gene hypomethylation -possibly via increased gene expression and consecutively decreased serotonin and/or norepinephrine availability -to potentially drive impaired antidepressant treatment response in female patients might be worthwhile to be followed up in larger pharmacoepigenetic studies .